Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Equity: 2021-2025

Historic Return on Equity for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to 0.01%.

  • GeneDx Holdings' Return on Equity rose 43.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 43.00%. This contributed to the annual value of -0.22% for FY2024, which is 51.00% up from last year.
  • Per GeneDx Holdings' latest filing, its Return on Equity stood at 0.01% for Q3 2025, which was up 39.08% from 0.01% recorded in Q2 2025.
  • GeneDx Holdings' 5-year Return on Equity high stood at 2.79% for Q3 2021, and its period low was -1.83% during Q1 2023.
  • Its 3-year average for Return on Equity is -0.71%, with a median of -0.59% in 2024.
  • In the last 5 years, GeneDx Holdings' Return on Equity slumped by 326bps in 2022 and then soared by 125bps in 2024.
  • GeneDx Holdings' Return on Equity (Quarterly) stood at -0.63% in 2021, then slumped by 72bps to -1.35% in 2022, then soared by 62bps to -0.73% in 2023, then surged by 50bps to -0.23% in 2024, then spiked by 43bps to 0.01% in 2025.
  • Its Return on Equity was 0.01% in Q3 2025, compared to 0.01% in Q2 2025 and -0.15% in Q1 2025.